Phenformin and ataxia‐telangiectasia mutated inhibitors synergistically co‐suppress liver cancer cell growth by damaging mitochondria

Inhibitors of ataxia–telangiectasia mutated (ATM), such as KU‐55933 (Ku), represent a promising class of novel anticancer drugs. In addition, the biguanide derivative phenformin exhibits antitumor activity superior to that of the AMPK activator metformin. Herein, we assessed the potential combinator...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Tianyu, Zhou, Sichun, Qin, Mei, Tang, Jing, Yan, Xinjian, Huang, Lingli, Huang, Meiyuan, Deng, Jun, Xiao, Di, Hu, Xin, Wu, Jingtao, Yang, Xiaoping, Li, Gaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091576/
https://www.ncbi.nlm.nih.gov/pubmed/33742560
http://dx.doi.org/10.1002/2211-5463.13152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091576/
https://www.ncbi.nlm.nih.gov/pubmed/33742560
http://dx.doi.org/10.1002/2211-5463.13152

Ejemplares similares